EGFR and neoplasm: It has been suggested that resistance to ICI in EGFR-mutated NSCLC is due to reduced TMB in the EGFR-mutant group compared with wildtype EGFR, or a ‘cold’ uninflamed tumor microenvironment which is immunosuppressive and reduced interferon gamma signature due to CD73 overexpression [95].